Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

maveropepimut-S (MVP-S) - BioVaxys

cyclophosphamide - Generic mfg.

Keytruda (pembrolizumab) - Merck (MSD)

https://ashpublications.org/blood/article/142/Supplement1/6124/500623/Intensity-of-Survivin-Expression-Correlates-with

Sila Usta; Alexandra Misura; Kim Roos; Iran Rashedi; Irina Amitai; Yidi Jiang; Kathryn Mangoff; Gail Klein; Nicholas Allen Forward; Douglas A. Stewart; Joy Mangel; George A. Tomlinson; Hubert Tsui; Neil Berinstein

Dec 3, 2023